1. A timing structure seating in a cam cover mounted on an engine, comprising:
legs to which a sensor assembly is fastened; and
an annular body that includes a first annular member with slits for receiving fasteners to tighten for securing a timing position or to loosen for timing adjustment, the annular body further including a second annular member that protrudes from the cam cover.
2. The timing structure of claim 1, wherein the sensor assembly is secured on a circular base and the circular base is fastened to the legs.
3. The timing structure of claim 1, wherein the second annular member includes two sets of holes adapted to receive fasteners to secure a timer cover.
4. The timing structure of claim 1, wherein the annular body further includes another sensor assembly being secured to the second annular member.
5. The timing structure of claim 1, wherein the annular body further includes a third annular member, the third annular member and the second annular member protruding from the cam cover.
6. An ignition system for a motorcycle engine, comprising:
a cam cover with multiple annular chambers, multiple marks being spaced apart and defined on a neck of the cam cover indicating degrees to which timing adjustment can be made; and
a timing structure with annular members that are seated into the multiple annular chambers of the cam cover, one of the annular members protruding from the cam cover and being adapted for gripping to adjust timing.
7. The ignition system of claim 6, wherein the timing structure further comprises legs to which a sensor assembly is fastened.
8. The ignition system of claim 7, wherein the timing structure further comprises an annular body that includes annular members, a first annular member with slits for receiving fasteners to tighten for securing a timing position or to loosen for timing adjustment, the annular body further including a second annular member that protrudes from the cam cover.
9. The ignition system of claim 8, wherein the annular body further includes another sensor assembly being secured to the second annular member.
10. The ignition system of claim 9, wherein the annular body further includes a third annular member, the third annular member and the second annular member protruding from the cam cover.
11. A method for adjusting the timing of a motorcycle engine, comprising:
loosening fasteners that secure a timing structure to a cam cover; and
grabbing an annular member of the timing structure that protrudes from the cam cover and rotating the annular member to adjust the timing without looking at a view hole to determine desired timing adjustment.
12. The method of claim 11, further comprising tightening the fasteners to secure the timing structure to a particular timing adjustment.
13. The method of claim 11, wherein rotating includes rotating clockwise by an increment marked by markers on a neck of the cam cover, each increment being indicative of about 2 degrees of timing adjustment.
14. The method of claim 11, wherein rotating includes rotating counter-clockwise by an increment marked by markers on a neck of the cam cover, each increment being indicative of about 2 degrees of timing adjustment.
15. The method of claim 11, wherein the timing structure is adapted to retain multiple sensor assemblies.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
We claim:
1. The use of at least one GD3 synthase inhibitor for the preparation of a pharmaceutical composition for the treatment of neuropathological disorders and signs, symptoms and dysfunctions associated therewith.
2. The use as claimed in claim 1 for treating cerebral ischemia.
3. The use as claimed in claim 2 for treating stroke, preferably acute stroke.
4. The use as claimed in claim 1 for treating traumatic damage to the brain and spinal cord.
5. The use as claimed in claim 1 for treating neurodegenerative disorders.
6. The use as claimed in claim 5 for treating dementia, especially Alzheimer’s dementia, parkinsonism, ALS, multiple sclerosis.
7. A process for the preparation of a pharmaceutical composition for the treatment of neuropathological disorders, wherein at first a GD3 synthase inhibitor is selected from a variety of substances and this inhibitor is then used in the preparation of the pharmaceutical composition.